tiprankstipranks
Opco lists five potential biotech targets into JPMorgan conference
PremiumThe FlyOpco lists five potential biotech targets into JPMorgan conference
1M ago
Stephens lays out 21 Best Ideas for 2025
Premium
The Fly
Stephens lays out 21 Best Ideas for 2025
1M ago
Needham adds Axsome to Conviction List, removes Blueprint
Premium
The Fly
Needham adds Axsome to Conviction List, removes Blueprint
3M ago
Blueprint Medicines price target lowered to $151 from $153 at Wells Fargo
PremiumThe FlyBlueprint Medicines price target lowered to $151 from $153 at Wells Fargo
3M ago
Blueprint Medicines Reports Strong Q3 2024 Results
Premium
Company Announcements
Blueprint Medicines Reports Strong Q3 2024 Results
3M ago
Blueprint management moves maybe made with buyer in mind, says Oppenheimer
Premium
The Fly
Blueprint management moves maybe made with buyer in mind, says Oppenheimer
3M ago
Blueprint Medicines price target raised to $127 from $112 at Baird
PremiumThe FlyBlueprint Medicines price target raised to $127 from $112 at Baird
6M ago
Blueprint Medicines price target raised to $130 from $125 at Oppenheimer
Premium
The Fly
Blueprint Medicines price target raised to $130 from $125 at Oppenheimer
6M ago
Blueprint Medicines raises 2024 product revenues view to $435M-$450M
Premium
The Fly
Blueprint Medicines raises 2024 product revenues view to $435M-$450M
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100